Ligand Pharmaceuticals Financial Health
How is Ligand Pharmaceuticals's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: LGND's short term assets ($220.4M) exceed its short term liabilities ($135.2M).
Long Term Liabilities: LGND's short term assets ($220.4M) exceed its long term liabilities ($99.1M).
Debt to Equity History and Analysis
Debt Level: LGND has more cash than its total debt.
Reducing Debt: LGND's debt to equity ratio has reduced from 52.2% to 9.4% over the past 5 years.
Debt Coverage: LGND's debt is well covered by operating cash flow (146.2%).
Interest Coverage: LGND's interest payments on its debt are not well covered by EBIT (0.7x coverage).